FN1 and malignant colon neoplasm: Whether treatment with immune checkpoint inhibitors such as pembrolizumab is more effective in Fn enriched colon cancer harboring MSI-H and whether changes in enrichment status of Fn are evident after immunotherapy are interesting questions to be studied in the future.